Liver Cancer
Early liver cancer assessment uses biomarkers of bile flow, hepatocyte injury, and synthetic capacity. At Superpower, we test Bilirubin, ALP (alkaline phosphatase), GGT (gamma‑glutamyl transferase), and Albumin for Liver Cancer assessment to track cholestasis, ductal injury, and protein synthesis, helping flag cancer‑related liver dysfunction early.
Lung Cancer
Biomarker testing illuminates how lung cancer disrupts body chemistry and stress pathways. Shifts in sodium (hyponatremia from SIADH), calcium (hypercalcemia via PTHrP), and cortisol (ectopic ACTH/Cushing) reveal tumor activity and systemic burden. At Superpower, we test Sodium, Calcium, and Cortisol to track these paraneoplastic signals for Lung Cancer.
Ovarian Cancer
Biomarker testing helps detect early biologic signals of ovarian disease, when symptoms are subtle. At Superpower, we track hormone balance and inflammation—Estradiol (E2), ESR, and CRP—to illuminate ovarian and systemic activity that can accompany tumor growth, progression, or benign conditions, guiding timely evaluation and surveillance.
Pancreatic Cancer
Biomarker testing helps flag early pancreatic and biliary stress before symptoms escalate. Changes in bile flow and liver-enzyme patterns can signal obstruction from pancreatic disease. At Superpower, we test Bilirubin, ALP, and GGT to detect cholestasis and biliary obstruction—key physiologic clues in pancreatic cancer risk assessment.
Prostate Cancer
Biomarker testing helps detect prostate changes early, before symptoms. PSA reflects how prostate cells are functioning and shedding protein into blood (prostate-specific antigen). At Superpower, we test for PSA Total and Free PSA to gauge cancer risk and differentiate benign enlargement or inflammation from malignant activity.
Smoking-Related Inflammation
Smoking provokes persistent, body-wide inflammation that strains vessels and immunity. Biomarker testing shows this physiology in real time. At Superpower, we track high‑sensitivity C‑reactive protein (hs‑CRP), white blood cell count (WBC), and the neutrophil‑to‑lymphocyte ratio (NLR) to quantify inflammatory load and immune dysregulation from smoking.
Systemic Lupus Erythematosus
Biomarker testing clarifies Systemic Lupus Erythematosus activity by showing immune inflammation and marrow effects on blood cells, signaling organ stress. At Superpower, we test WBC (leukocytes), Platelets (thrombocytes), Hemoglobin, ESR (erythrocyte sedimentation rate), and CRP (C‑reactive protein) to gauge disease activity and systemic burden.
Testicular Cancer
Biomarker testing reveals testicular function and tumor-driven hormone disruption early. Patterns in sex-steroid balance show gonadal health and potential neoplasm effects. At Superpower, we measure estradiol and testosterone to assess endocrine dynamics (estrogens, androgens), which can shift in testicular cancer via hormone secretion or impaired Leydig-cell function.
